Back to News
Market Impact: 0.3

High Tide Inc. (HITI) Stock Drops Despite Market Gains: Important Facts to Note

HITISPYDIAQQQNNOX
Corporate EarningsAnalyst EstimatesCompany FundamentalsHealthcare & BiotechMarket Technicals & Flows
High Tide Inc. (HITI) Stock Drops Despite Market Gains: Important Facts to Note

High Tide Inc. (HITI) shares declined 1.69% to $2.32, underperforming the S&P 500's 0.55% gain, and have lagged both the Medical sector and the S&P 500 over the past month. The company's upcoming earnings release on June 16, 2025, is expected to show a 5.6% increase in quarterly revenue to $96.73 million, while annual estimates project a 6.11% revenue increase to $404.52 million but a 75% decrease in earnings per share to -$0.07. High Tide currently holds a Zacks Rank of #3 (Hold), with its industry ranking in the bottom 40% of all industries.

Analysis

High Tide Inc. (HITI) recently saw its stock decline 1.69% to $2.32, underperforming the S&P 500's 0.55% gain, the Dow's 0.25% rise, and the Nasdaq's 0.63% increase. This underperformance extends over the past month, with HITI shares losing 0.42%, contrasting with the Medical sector's 3.49% gain and the S&P 500's 6.29% advance. The company's forthcoming earnings release, anticipated on June 16, 2025, is projected to show quarterly revenue of $96.73 million, an increase of 5.6% year-over-year. For the full year, Zacks Consensus Estimates forecast earnings of -$0.07 per share and revenue of $404.52 million, representing shifts of -75% in EPS and +6.11% in revenue, respectively, from the prior year. Despite the general principle that upward estimate revisions signal analyst optimism, the Zacks Consensus EPS estimate for High Tide Inc. has remained stagnant over the past month. Consequently, HITI carries a Zacks Rank of #3 (Hold) and operates in the Medical - Products industry, which ranks in the bottom 40% of all industries (Zacks Industry Rank 148), suggesting broader challenges within its peer group.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo